Rankings
▼
Calendar
RNA FY 2020 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RNA
Avidity Biosciences, Inc.
$2B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
+192.7% YoY
Gross Profit
-$31M
-454.0% margin
Operating Income
-$44M
-652.4% margin
Net Income
-$44M
-653.5% margin
EPS (Diluted)
$-2.05
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$38M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$334M
Total Liabilities
$28M
Stockholders' Equity
$306M
Cash & Equivalents
$321M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$2M
+192.7%
Gross Profit
-$31M
$2M
-1428.8%
Operating Income
-$44M
-$17M
-155.5%
Net Income
-$44M
-$25M
-79.3%
← Q4 2019
All Quarters
Q1 2020 →